首页> 外国专利> AZELAIC ACID COMPOSITION HAVING ADIPOSE TISSUE TRIGLYCERIDE DEGRADATION EFFECT

AZELAIC ACID COMPOSITION HAVING ADIPOSE TISSUE TRIGLYCERIDE DEGRADATION EFFECT

机译:具有脂肪组织甘油三酯降解效果的偶氮酸组合物

摘要

The present invention relates to a pharmaceutical composition or a functional food containing azelaic acid as an active ingredient and, more specifically, to a pharmaceutical composition and a health functional food, which contain, as an active ingredient, azelaic acid having an effect of lowering the accumulation of triglycerides, by allowing Olfr544, which is a GPCR expressed in cell membranes of adipose tissue, to be activated through coupling with azelaic acid such that the hydrolysis of triglycerides in adipose tissue is promoted through a cAMP-PKA-HSL signaling pathway. The composition containing azelaic acid, according to the present invention, has an excellent effect in the alleviation of the accumulation of lipids in adipose tissue and of the lipid metabolism of adipose tissue, thereby being usable as a food material, a pharmaceutical composition, and a health functional food for alleviating the lipid metabolism of adipose tissue (obesity alleviation) such as in body weight reduction and body fat reduction.
机译:本发明涉及含有偶氮酸作为活性成分的药物组合物或功能性食品,更具体地,涉及药物组合物和含有作为活性成分的偶氮酸的医药组合物和健康功能食品,其具有降低的效果通过允许OLFR544允许甘油三酯的积累,即脂肪组织的细胞膜表达的GPCR,通过与偶氮酸偶联而被激活,使得通过CAMP-PKA-HSL信号传导途径促进脂肪组织中甘油三酯的水解。根据本发明的含有偶氮酸的组合物在减轻脂质组织和脂肪组织的脂质代谢中的脂质的积累具有优异的效果,从而可用作食品材料,药物组合物和a用于减轻脂肪组织(肥胖减轻)的脂质代谢的健康功能食品,例如体重减轻和体脂减少。

著录项

  • 公开/公告号EP3318254B1

    专利类型

  • 公开/公告日2021-04-21

    原文格式PDF

  • 申请/专利权人

    申请/专利号EP20160821568

  • 发明设计人 LEE SUNG-JOON;

    申请日2016-06-27

  • 分类号A61K31/20;A23L33/105;A23L33/115;A61P3/04;

  • 国家 EP

  • 入库时间 2022-08-24 18:19:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号